Clinical trials in Delft – page 103

1 232 clinical trials in Delft, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Delft at a glance

1 232

clinical trials

Research sites1

Quick filters

1 232 trials in Delft

Open in trial search

Dermatitis atopic

Not recruiting

Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

Registered drugNo placebo

Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Dupilumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Hormone-refractory prostate cancer

Not recruiting

Study Comparing Docetaxel Alone and Docetaxel with Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

Study Comparing Docetaxel Alone and Docetaxel with Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Radium RA 223 dichloride
Sponsor:Memorial Sloan Kettering Cancer Center

Contact Research Centre

Gastrooesophageal cancer

Not recruiting

Study on Liposomal Irinotecan, Carboplatin, or Oxaliplatin for First-Line Treatment in Patients with Advanced Esophagogastric Cancer

Registered drugNo placebo

Study on Liposomal Irinotecan, Carboplatin, or Oxaliplatin for First-Line Treatment in Patients with Advanced Esophagogastric Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Cardiac failure+4

Not recruiting

Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

Registered drug

Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:CDR132L
Sponsor:Cardior Pharmaceuticals GmbH

Contact Research Centre

Thermal burn

Not recruiting

Study on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents

InvestigationalNo placebo

Study on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Sponsor:Cutiss AG

Contact Research Centre

Mantle cell lymphoma stage II+2

Not recruiting

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Ibrutinib
Sponsor:Klinikum der Universitaet Muenchen AöR

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

Registered drug

Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Durvalumab
Sponsor:Clinipace Global Limited

Contact Research Centre

Narcolepsy

Not recruiting

Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

Investigational

Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:ALKS 2680
Sponsor:Alkermes Inc.

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 101 cities in the Netherlands

Clinical research in Delft

What the registry says about research in the country

01 Cardiovascular Research

Clinical trials focusing on cardiovascular disease management and prevention, including studies of novel treatments for atherosclerotic cardiovascular disease and innovative therapies targeting lipoprotein reduction.

Lipid Management Studies
Cardiovascular Risk Prevention
Major Adverse Cardiac Events

Research exploring both established and experimental treatments to reduce cardiovascular complications and improve patient outcomes.

02 Oncology Studies

Comprehensive research into various cancer types, with significant focus on prostate cancer, breast cancer, and blood cancers including chronic lymphocytic leukemia.

Advanced Imaging Techniques
Targeted Therapies
Treatment Combinations

Innovative approaches combining established treatments with novel therapeutic agents to enhance treatment effectiveness.

03 Women's Health

Studies addressing various aspects of women's health, including infertility treatments and management of uterine fibroids.

Reproductive Health
Gynecological Conditions
Quality of Life Studies

Research comparing different treatment modalities and their impact on patient outcomes and quality of life.

Back to the Netherlands All countries